In prostate cancer, activated ACK1 promotes tumor growth via androgen receptor (AR) tyrosine phosphorylation, facilitating androgen-independent transactivation of AR (Mahajan et al., 2007) and degradation of tumor suppressor WW domain containing oxidoreductase (Wwox) (Mahajan et al., 2005). Here, AR is linked to neoplasm.